Gabelli Funds LLC Increases Stock Holdings in Electromed, Inc. (NYSE:ELMD)

Gabelli Funds LLC boosted its stake in Electromed, Inc. (NYSE:ELMD) by 7.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 38,675 shares of the company’s stock after acquiring an additional 2,808 shares during the quarter. Gabelli Funds LLC’s holdings in Electromed were worth $581,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Pekin Hardy Strauss Inc. purchased a new position in shares of Electromed in the second quarter valued at $522,000. Gamco Investors INC. ET AL boosted its position in Electromed by 32.6% in the 1st quarter. Gamco Investors INC. ET AL now owns 111,356 shares of the company’s stock valued at $1,798,000 after buying an additional 27,356 shares during the last quarter. Morgan Dempsey Capital Management LLC acquired a new stake in shares of Electromed during the second quarter valued at about $108,000. Vanguard Group Inc. increased its position in shares of Electromed by 1.6% during the first quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock worth $5,929,000 after acquiring an additional 5,886 shares during the last quarter. Finally, Hunter Associates Investment Management LLC increased its position in shares of Electromed by 7.1% during the first quarter. Hunter Associates Investment Management LLC now owns 86,200 shares of the company’s stock worth $1,391,000 after acquiring an additional 5,700 shares during the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Stock Performance

Shares of ELMD opened at $19.64 on Friday. Electromed, Inc. has a one year low of $9.53 and a one year high of $20.81. The stock has a 50-day moving average price of $16.51 and a 200 day moving average price of $15.97. The company has a market capitalization of $170.00 million, a P/E ratio of 39.28 and a beta of 0.27.

Electromed (NYSE:ELMD) last released its quarterly earnings results on Tuesday, August 27th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.06. The business had revenue of $14.83 million during the quarter. Electromed had a net margin of 9.41% and a return on equity of 12.44%.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.